Philip Morris
Indoor Passive Smoking: Its Effect on Cardiac Performance
Fields
- Author
- Bertanelli, F.
- Fabiano, P.
- Filippelli, M.
- Leone, A.
- Mori, L.
- Fabiano, P.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Characteristic
- EXTR, EXTRA
- Site
- R529
- Named Organization
- St Lukes Health Sciences Library
- Author (Organization)
- City Hospital Pontremoli
- Intl Journal of Cardiology
- Named Person
- Leone, A.
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- ejc02a00
Document Images
ST. LUKE'S HEv;L?H SC1Ep;!'gS LIBRAPY
trcti~e: T~ n;l: ;el t y G ct_:!ed
by copylight lLlv (i)tle 17 U!S. Code).
lnrrrnauun)r/ Journal'o(Cardrolug%: 3? /~1y91 )'_17-L5,, 24-
c : 19`)1 Llkesicr Science Publuhers B:V. All rights reserved 0167-5273/9li/S03.50
.aDO VIS 01h'S'73H 100=36Z
CAR'DIO 01349
Indoor passive smoking: its effect on cardiac performance
A. Leone, L. M'ori, F. Bertanelli, P. Fabiano and M. Filippelli
Dfnsiun of AJrdicine. Crtt Hospital Ponrrrmoli. Lunigiana. Imis
(Recei.rd .4 December 199U: revision accepted'_U Muy 1991/',
Leone A. 41ori L. Bertanelli F. Fabianu. P: Filippelli M. Indoor passive smoking: its eflfact on
cardhac
performance. Int J Cardiol 199'1:33:'_-i7-'_5'_.
We studied 19 nonsmoker male volunteers. 9 hcalths ('mean age 30.4 = 8.51, and 10 w-iih preciuus
m}ocardiai infarction (mean age 43.8 =5.3), who underwent exercise stress testing twice: in a
smuke-frec
environment an& in a smoking environment (carbon monoxide concentration 30-35 ppm). We measure&
peak exercise power. time to reco.er} of pre-exercise heart rate, expired concentration of carbon
monoxide and plasma carbon monoxide. Obtained data were compared by using t-test. P < 0:0: was
statistically significant. Mean data observed in healthy people were as follo..s. Peak exercise
power
220 = 30 watts in a smoking environment versus 220 = 30 in a smoke-free environment (P> 0.05). Time
to recosery of pre-excrcise heart rate 19 -_ 4 minutes in a smoking environment versus 8.5 _4 in a
smoke-free environment ( P < 0:0C): Expired concentration of carbon monoxide before exercise :-3 =
2.01
ppm versus 8.5 = 1.6 (P< 0.01) after exercise in a smoking environment, and 2.3 = 2 ppm before
exercise varsus 2.1 = 1.9 after exercise in a smoke-free en\ironment ( P> 0.0: ). Plasma carbun
munu\id'e
before exercise 1.4 = 0.:17c versus1.7 _ 0.,3 after exercise in, a smoking en%irnnment ( P> 0.04),
and
1.2 = 0:arc before exercise versus 1.2 = 0A in a smoke-free environment ('P > 0.115 )'.
Corresponding
measurements in survivors of infarctiun were as fulluws: peak exercise puwcr 80 = 25 watts versut,
120 -_ 20 ( P< 0.01), time to recovery of pre-cxercise heart rate :I = 2.5 mi'nutes \ersus 1_'.3 -
2.0
(~P 0.01), expired' carbon monoxide 0.6 = 0._' ppm %ersus 5'= 1.2 (1P' < 0.01) in a smoking ent
irtln-
mc,tt andl 1.2 - 0.8 versus 1.3 _ 0.6 ( P> 0.05) in a smoke-free cn.ironment. plasma carbon monoxide
1.?' = O:f61c .ersus 23 ± 0.4 ( P< 0.01) in a smoking en.irunment and 1.2 y 0.1 versus 1.2 = 03 ( P
>
0:05) in a smoke-free environment. Cardiac response to the exercise is significantly wursened by
passi\c
smukec especially in those subjects with pre.ious myocardial infarction.
Key'wttrd's; Passive smoking: Infarcted people
, Introduction [ li-.3J. A strongly incriminating relatiunship bc-
twern cigarcttc smoking an& mvucardiai inf'urc-
Stnoking interferes negatii.ely with cardiitc per- fion, has been shown by numerous studie.
formance and is responsible for uarcliuc pnthulug} but a quantitative assessment of the
alteratiunN
caused', aruteli~ hy passi\c smoking on cardia~
performance in hcalthy peopll and those ..ith
rnmp.rndrner r.- IDr'. \ur./nl Lomr. \t.D.. \~I:1i Phm tn~ prC\'It1tlSmYt9carljlall lnl:lrcLrln
h;lN nol, \,:t' h,.c.1Y
~-..;'1II")'l .I,Icllltlr-a \l.Ilr.111PI: ll.ll{. Cltah6hclj.

241
The purpose of this study was to investiEate,
quantitatively. the effects of' passive smoking oncardiac performance of healthy people and'thosc
winhiprcvious myocardial infarctionL
Materials and Methods
19 nonsmoker male volunteers (Table 1'J, 9
healthr aged from 17 years to 4431years (mean, age
with 1 standard deviation 30.5 ± 8.5 years), and
10 with previous myocardial infarction aged, from
43 years to59 ycars (mcan, age with ± standard
deviation, 518 ± 5.3 years) were studied. The
healthy people had no history of any illnesses at
all.. Their resting 12-lead electrocardiogram wati
normal. The suhjccts, who survivec1' a first acute
mvocarclial infarction; had had an.anterior infarc-
ticm in 5 cases and an inferior infarction in 5
cases. All suhjcct,. gave their: informed cun.c:n1 to
he inclucJed! in this,stud\.
The studietli population undLr..cnt exercise
stress testing on a bicycle ergomcterl tW ice: the
first time, the subject perf'urmed the exercise in
sixtn cubic metrrs enclosed space not polluteti' h%
cigarette smoking. On the second occa,ioni the
amhicnt: atmrrsphcrc was polluted by 3t)-35 ppm
carbon monoxide concentration we reached hs
the combustion of 15 to 2U1ciiarcttcs within half
an hour hy utiing a,witchmer machine connected
to a Procr;tmmahlc In1ru-rLd SpectnophutomctCr
at Variable Pathwav (Wilks Mhd. ttiO'). This device
allinticd u; to mcanurc carbon monoxide comccn-
rm1sLL I
tration and maintain it at the desired le%el during
exercise stress testing. Each studied subject was
test and control ofl himself.
During and: after exercise, electrocardio-
graphic Ieads V2-V6 were displayed continuouslti
on a monitor scope, and once every . minute a
12-lead electrocardiogram was recorded'. Sjstolie
blood pressure was also~ recorded~ with a sph,,g-
momanometer during the last. minute of the excr-
cise,
In each studied subject we assessed the peak
exercise power, time to recovery of pre-exerci,c
heart rate and~ carbon.monuYidc concentration of'f
both expired air and plasma before and af2ar
exercise.
Statistical methods
Standard statistical methods were usco. All
data were compare& by using the r-te,t !''< u.u5
was taken to denote statistical siLnificancc. The
data arc presented as means - SD.
Results
The result, t)1 this studr are summarized tmi
the Tables 2-5. Peak exercise prt%ccr (Table 2) of
healthy people ranged from I4U~ to 260 u ttts
(mean '_2(l - 3(1) in a .mt>hc-Crcr emironmupnt..
and! frumi 1'SO to '_bl) «att. lmcan; 22f/1-_ ?O4 in a,
smoking environment. The rorrespcondin_ fiLurr.
in survivttrs o( infarctitm wurr 8(1 tu I-40 %kattN
(mean 120 - ,f)) in a smo{,u-ticr cminonrncnt.
and~(i(1 to 1211 watts (mean \tl='-5) in a,mokrne,
environment. a statisticalk tiicnlticant Liltfcrcncc
(P<(I.t111.
Time to rccoverv of prc-cxerci.e heart rate
(Table 3) for he;tlth~ people was -i'i to I`s" minutc..
I tcatthy pcort)c
Numhrr
9
Mran agc (years) 30:5=K.5
Sex (mrlc) 9 TADLL ?
CIwruclcr .iics uf thr .tudird n ipuLwun.
Nirpreviuuti medical history
Survivors of infarctiun
Number
t) t'cak exereise tx>`aer (satta, mean -_ SD, in the .tud rd r>+nu-
lauom.
Mean age (years) .
53,K±
5.3
Subtrcts,
Smoking
Jmnle-trce
r-tc.t
Sex (male) ttl' cnvtrnnmrnt rn% tronmn nl
infarction
anterior
inferior tt)
55
S Ilu:ttthy penr,tc
Sunisor. .11
ml:irctiomi __n-_ tn
ti11-.~ __n-_
1_11-_I1
J. u,ol

:49.
"I A{iLE 3
Time to reco.en oflpre-rzerctse heart rate (mmutesl, mean-
SD: in the stuJteJ pupuiauun.
Subjects Smoking
' enN ir(lnmenl Smoke-free
environment I-rest
Hs;ilth% people 19_-a 8L(i_.i P<0.011
Survivurs of
infarction,
21- ::5
1'_:3/) -?
P < 0.011
(mean 8.50 ±.3) in a smoke-free environment.
and H toi_'5 minutes (mean 19'y 4) in a smoking
environmenti with a statisticalh significant differ-
ence PP < Uj01). The corresponding parameterss
in survivors of intarcniun ranged Erom, 10 to 15
minutes (mein 11, _10), im a smoke-free ern i-
ronmtnn. and from IS to 2,; minutes (mean 21 =
2.50) in the envirunmant polluted by cigarette
Smctke., a Ytclristic:tll> >i_ntticant dilt'urcncc (P <
t).111 ).
The rcsultN cunccrnin-g, the ctmccntration of
cxpircJ' uancon munu.\idc are di,pla}u7J' in Table
4. In hraltfi% ~oluntecr, thcrc vas ntl dittercncc
in the values priclr tu J\crciNr betweLn the smok-
in_ and smoi.r-trcc umirunmrnts (2..'+ =_'.01 ver-
,tiuN _. 3- 2'.0': ppm ). In the smuke-t'ree em inrn~
l -
ment. thrre .vus nu sl_nificant chan=e aftcr exer-
cisc (2.11= 1.9! /'> (LII5). svhurcati in thr :mc)kin_
environment there %%a:, a,i_niticant increa,e lto
T.\131.L J'
8'.5 ± 1.6. P < 0.01) after exercise. In survivors of'
myocardial infarction. the concentration prior to
exercise was significantly lower in the smoking
environment than in the smoke-free environment
(0.6 ± 0.2 versus- 1.2 ± 0:8, P < 0:05). In the
smoke-free environment, there was no significant
change in the concentration after exercise ('13 ±
06, P> 0.05), whereas in the smoking environ-
ment there was a significant increase (to 5.2.± 1.2,,
P < 0!01)~after exercise. Although the two groups
had different age distributions, there was no sig-
nificant difference inithe measurements between
thc survivors and the healthy voluntcers. except
for the concentration of' espired carbon monoxide
after, exercise in the smoking environment
(healthy 5.5 -- 11.6 versus survisors 1.2. P <
Ua01 ).
The results uf, cconcentration of csrbon monox-
ide in the planmu arc cJiSpla%ud in Table 5. lin~
hcalth~ %wlunteer, there v.as no dilltcrr%e in thr,
result~ prior to exercise between the :mokinz antj'
smukc-trcr em irunmentv ( 1.-t =0.: \er,us 1._ =
0.a''r' )~ In, neither the timokin_ environmc.rn~ nor
thc smoke-free environment \&as there a signifi-
cant change after exercise (1.7 = U:4. P > U!O5and 1..'_ U.-i'. P>(1.05. re,pecu\ely): In ,ur,i.or,
of intarction there was no dilterence in the pre-
exercise concentration het>,.rvn ttie smoking anS
smokr-trec rn\ irtmmentn (1.2 _ 1):ln rersu% l.' =
I:-qitrcil .':irh,m nwn,na,fe lTrpml: mc.in = 11), in the tuJi.J n thul.itin.
Sultrrt 1moF,mi tmtnmment
licatthy pooplc
Sunn+v, nltNUrcuoni
nlea hc;tlth\ ,,wrn nor.
rPR'-CXCrct.C Pu.lrv\l'rUtSl Ir I C..t
_.. __.tll 1,"- Ln P~ 11.111
U:n-11.: 5'-l._ l':IL111
P> 0:1)i' P<(EII I
TABLE
~
Pta.ma r:tr(wm mom+siJe ma:tn + 5D: in the studieJ txtpulau m.
Suhlcets Smoking omvtutnment
Ptr-etrrcue Pna-exercise /.test
t1Lalthy petiplc ILJ -_ Il::. I.;'-_ 11.4 P> 0,05
5utvi.ott, of inl:trcuwm II' - Il:Ifr, _:3,+ 11.4 P< O.INII
1moL,'c ttuu rnriranmrnt,
Prc-rWri ur Ro.trwrrt.a r-te.t
L:-tl.ti
1.z_0.6 P> U~Ufi
P>(1;05
P > u:u5 P > 0.05,
Smoke-free environment
Pre-exercise Post-exercise r-sesl
1..'= ILa 1 LZ -_ 04 P> I1:0I;
1.:'- 0;1 lL'_ -(1:3, P> I1;1)5
'
rtr.tho:dthM unrn,irn P ilif~' f:IIJ)~ P>(1.04Z P> 0 I14Z

250
0.1). In the smoke-free environment,, there was
no significant change in the plasma concentration
after exercise (1.2 ± 03, P> 0.05), whereas in the
smoking environrnent there was a significant in-
crease (to: 2.3 ± 0.4, P< 0.01) after exercise. AI1
though the two groups ha& different age distribu.
tions, there was no significant difference in the
plasma carbon monoxide measurements between
the survivors and the healthy volunteers, except
for the post-exercise plasma carbon monoxide in
the smoking environment (healthy 1.7 ± 0.4 ver-
sus survivors 2.3 ± 0.4,, P < 0.05 )!
Discussion.
For many people, exposure to environmental
tobacco smoke is a potcntiall hazard' of daily life.
We planned this study since of many air pollu-
tants, the components of cigarette smoke have an
vrigin both indoors and outdoors [7], and can
cause serious effects on the cardiovascular system
[8]l
Cigarette smoking can lead to catccholaminc
release which enhances platelet adhesiveness.
Cigarette smoking and', nicotine may also increase
myocardial electrical instability: heart rate and
systolic blood pressure exacerbating the athero-
scicrotic process. Carbon monoxide increases the
blood's carboxyhcmoglobin lcvel'because its affin-
ity for hemoglobin is much greater than that of
oxygen, diminishes oxygen transport capacity and
damages directly myocardial mitochondria and;
endothclium [9]:
Cardiac effects are the result of the degree of
exposure to~smoking and usually do~not become
apparent for days after exposure 110). The acute
response of the heart to passive smoking has not
yet been carefully evaluated. Our data seem to
show two different types of response, the one for
the healthy subject and' the other for the subject
with previous myocardial infarction. However,,
some characteristics were similar.
A significant reduction of peak exercise power
(33.4% in this study) has been seen im people
with previous myocardiali infarction who have un-
dergone exercise stress testing ima a smoking cnvi-
ronment compared to their response inia;smukc-
free environment ( P< 0.01'1). Healthy people did
not have impaired' peak exercise power.
in a smoking environment time to recovery of
pre-exercise heart rate was prolonged in both
groups. In our opinion that may be the conse-
quence of decrease& environmentali oxygen avail-
ability. It is known indeed that the environmenn is
fundamental' for human, homeostasis, and de-
creased environmental oxygen is potentially
' harmful for life.
Three main observations on expired carbon
monoxide and plasma carbon~ monoxide can be
made from this study. Firstly, pre-exercise an&
post-exercise measvrements were similar or not
statistically different (P> 0.05) for all pcople in a,
smoke-free environment. Secondly, in a smoking
environment, post-exercise plasma carbon monox-
ide of survivors of infarction was statisticall.~
higher (P <0.05) than that of healthy people.
Thirdly, in the smoking environment post~ex-
ercise expired carbon monoxide was significantl%
lower (P <0.01) in survivors of infarction if com-
parc& to hoalthy controls. Although there is a
siEnificant, difference between the survivors and
healthy controls as regards their post-cxercise
expired carbon monoxide and plasmal carbon
monoxide, this may not necessarily ba due whollk
or even partiallyy to the previous myocardial in-
farction, as the two groups had different age
distributions. Since the values of cxpircd carbon
monoxide and plasma carbon monoxide prior to
exercise were similar (P> 0.U5)' in both groups.
we believe the previous myocardial infarction
combined with exercise stress testing in the smok-
ing environment is a responsible factor of the
aforesaid occurrence. Survivors of infarction of-
ten have cardiac failure, even if sometimes silent.
as a probable consequence of impaire&hacmod~-
namics. Such pathology may affect the blood gas
exchange as well as the ventilation/perfusion
ratio. However, this hypothesis should be further
investigated.
Acute exposure to passive smoke impairs the
cardiac performance of both survivors of infarc-
tion and hcalthy voluntccrs. Survivors, who often
have hacmodynamic impairment, should avoid in-
door %paees polluted by cigarette smoke. The f'ucn
that passive smoking also claarlj aff'cct.s the car-

diac measurements made in the healthy volun-
teers has implications for public health and legis-
lation.
References
1 Doyle JT, Dawber TR. Kannel WB. Kinch SH. Kahn HA.
The relationship of cigarette smoking to coronary heant
disease. 1 Am fuled~Assoc 1964;190:886-890:,
2 Hammond'EC, Garfinkel L. Coronary heart disease, stroke
and aortic aneurysm. Arch Environ Health 1969;19:167-
18'-.
3 Reid'DD. Hamilton PJS. McCartney P, Rose G. Jarret H.
Keen H. Smoking and other risk factors in coronary heart
disease in British ciNil sarvants. Lancet 1976:ii:979-9l+4:
4 Leone A. Tagliagambe A. Long-term prognosis of in-
farctrd smokers: is it affected by smoking ceasauon': In:
Aoki M, Hisamichi S, Tommaga~ S. eds. Smoking and
health 1987, Amsterdam. Elsevter/North,Hulland. 1988:
723-726:.
5 Kaufman DW;,Helmrich SPRosemberY L. Miettinen OS,
Shapiro S. Nicotine and earbon monoxide content of
cigarette smoke and the risk of myocardial infarction in
young men. New Engl J1 Mcd 1983,308:409-413.
6 Leone A, Lopez M. Oral eontraceptionovariao disorders
and tobacco in myocardial infarction of woman, PatholoY-
ica 1986;78i237-242.
7 Bell JNB. Comparative eriteria for indoor and'ambient air
quality-biology considerations. l'n:,Perry R, Kirk PW, eds.
Indoor and ambient air quality. London: Selper Lad,
1988:13-23.
8' Leone A. Passive smoking in infarcted patients: role of
indoor exposure. In: Perry R. Kirk PW. eds:. I'ndoor and
ambient air quality. London: Selper Ltd. 1'988.211-21a1
9' Astrup P. The arterial wall in atherogenesis. ln: Cavallero.
ed! Atherogenesis: Padua: Piccin Medieal' Book. 1965;77-
93.
1(li Moeschlin S: Poisoning. Diagnosis an& treatment. New
York: Grune Stratton- 1965'25-233.
